Fig. 1
From: Combined ultrasound–CT approach to monitor acute exacerbation of interstitial lung disease

Lung ultrasound score trend, computed tomography and clinical parameters during 93 days of extra-corporeal life support for acute exacerbation of interstitial lung disease in dermatomyositis–polymyositis (R rituximab, Ig immunoglobuline, Cs cyclosporine, NIV non-invasive ventilation, ECMO extra-corporeal membrane oxygenation—red dot: membrane lung replacement, HFNC-FiO2 fraction of inspired oxygen delivered by high flow nasal cannula, ML-FiO2 fraction of inspired oxygen delivered by the membrane lung, SGF sweep gas flow, PaO2 patient’s partial arterial oxygen pressure)